COVID-19 vaccine administered by nasal spray receives Phase I study approval in China

Clinical Research |  News | 0 Comment | 30 Sep, 2020

Pharma companies around the world are exploring innovative approaches to develop therapeutics and vaccines against COVID...Read more

Study reveals postoperative pain can be reduced by using NOL monitoring

Clinical Research |  News | 0 Comment | 30 Sep, 2020

A new study has found that monitoring pain response levels during surgery with NOL technology (Medasense, Ramat Gan...Read more

Samsung Biologics to develop treatment for retinal diseases with Kanaph Therapeutics

Clinical Research |  News | 0 Comment | 24 Sep, 2020

Samsung Biologics and Kanaph Therapeutics have entered into a strategic partnership to develop KNP-301, a bi-specific Fc...Read more

World's first clinical trial with Sirolimus Coated Balloon for the treatment of SFA begins

Clinical Research |  News | 0 Comment | 15 Sep, 2020

Singapore's Concept Medical Inc., focused on vascular intervention drug delivery devices, on 15 Sep 2020 has a...Read more

Taiwan reports first COVID-19 patient recovery with eIND Silmitasertib treatment

Clinical Research |  News | 0 Comment | 14 Sep, 2020

Taiwan's Senhwa Biosciences, Inc., a clinical-stage biopharmaceutical company focused on next-generation DNA Damage Re...Read more

Empagliflozin to reduce the combined relative risk of cardiovascular complications

Clinical Research |  Analysis | 0 Comment | 03 Sep, 2020

Full results from the EMPEROR-Reduced Phase III trial in adults with heart failure with reduced ejection fraction, with ...Read more

Duke-NUS joins TriNetX to increase clinical trial adoption

Clinical Research |  News | 0 Comment | 02 Sep, 2020

Duke-NUS, the only graduate-entry medical school in Singapore, has joined the US based TriNetX global research netw...Read more

BeiGene signs licensing agreement with Singlomics for COVID-19 Abs

Clinical Research |  News | 0 Comment | 02 Sep, 2020

The global company BeiGene, Ltd. and Beijing based Singlomics (Beijing DanXu) Biopharmaceuticals Co., Ltd., ha...Read more

CStone receives US FDA IND clearance to evaluate Sugemalimab Monotherapy

Clinical Research |  News | 0 Comment | 31 Aug, 2020

CStone Pharmaceuticals Co., Ltd. on 31 August 2020 announced that the US Food and Drug Administration (FDA) ha...Read more

Europital opening UK site for further expansion

Clinical Research |  News | 0 Comment | 27 Aug, 2020

Belgium based Europital, the global provider of medical management services for clinical research and drug dev...Read more

Novotech receives "2020 Frost & Sullivan Asia-Pacific CRO Company of the Year’

Clinical Research |  News | 0 Comment | 26 Aug, 2020

Novotech, the largest biotech specialist CRO in the Asia-Pacific region, was awarded the ‘2020 Frost & Su...Read more

Enrolment initiated in World's First RCT to treat BTK

Clinical Research |  News | 0 Comment | 27 Aug, 2020

Concept Medical Inc., focused on vascular intervention drug delivery devices, has announced the enrolment of the first p...Read more

Australia studies antimicrobial technology to eradicate SARS-CoV-2 on surfaces

Clinical Research |  News | 0 Comment | 27 Aug, 2020

  The Global Virus Network (GVN), a coalition comprised of the world's preeminent human and animal, announced that...Read more

Byondis Initiates Ph I trials of ADC as treatment of HER2-Expressing Solid Tumors

Clinical Research |  News | 0 Comment | 25 Aug, 2020

A Two-part Phase I Study With the Antibody-drug Conjugate SYD985 in Combination With Niraparib to Evaluate Safety, Pharm...Read more

AUM Biosciences establishes joint lab with SIgN

Clinical Research |  News | 0 Comment | 19 Aug, 2020

AUM Biosciences (AUM), a Singapore-headquartered clinical-stage biopharmaceutical company aiming to democratize R&D ...Read more

GC Pharma Files IND for Hyperimmune Globulin-based Therapy for COVID-19

Clinical Research |  News | 0 Comment | 03 Aug, 2020

Korean biotech, GC has applied for an investigational new drug application (IND) to conduct a Phase 2 clinical trial for...Read more

AstraZeneca's AZD1222 expresses robust immune responses in Phase I/II trial

Clinical Research |  News | 0 Comment | 22 Jul, 2020

Interim results from the ongoing Phase I/II COV001 trial, led by Oxford University, showed AZD1222 was tolerated and gen...Read more

Celltrion launches human trial of potential COVID-19 Ab treatment

Clinical Research |  News | 0 Comment | 23 Jul, 2020

South Korea based Celltrion Group has announced the launch of its Phase I human clinical trial investigating a potential...Read more